Abstract:Background: Variable responses to the Hepatitis B Virus (HBV) vaccine have recently been reported as strongly dependent on genetic causes. Yet, the details on such mechanisms of action are still unknown. In parallel, altered DNA methylation states have been uncovered as important contributors to a variety of health conditions. However, methodologies for the analysis of such high-throughput data (epigenomic), especially from the computational point of view, still lack of a gold standard, mostly due to the intrinsic statistical distribution of methylomic data i.e. binomial rather than (pseudo-) normal, which characterizes the better known transcriptomic data. We present in this article our contribution to the challenge of epigenomic data analysis with application to the variable response to the Hepatitis B virus (HBV) vaccine and its most lethal degeneration: hepatocellular carcinoma (HCC).Methods: Twenty-five infants were recruited and classified as good and non-/low-responders according to serological test results. Whole genome DNA methylation states were profiled by Illumina HumanMethylation 450 K beadchips. Data were processed through quality and dispersion filtering and with differential methylation analysis based on a combination of average methylation differences and non-parametric statistical tests. Results were finally associated to already published transcriptomics and post-transcriptomics to gain further insight.Results: We highlight 2 relevant variations in poor-responders to HBV vaccination: the hypomethylation of RNF39 (Ring Finger Protein 39) and the complex biochemical alteration on SULF2 via hypermethylation, down-regulation and post-transcriptional control.Conclusions: Our approach appears to cope with the new challenges implied by methylomic data distribution to warrant a robust ranking of candidates. In particular, being RNF39 within the Major Histocompatibility Complex (MHC) class I region, its altered methylation state fits with an altered immune reaction compatible with poor responsiveness to vaccination. Additionally, despite SULF2 having been indicated as a potential target for HCC therapy, we can recommend that non-responders to HBV vaccine who develop HCC are quickly directed to other therapies, as SULF2 appears to be already under multiple molecular controls in such patients. Future research in this direction is warranted.

[Association of DNA methylation of IFNG gene with no/low response to hepatitis B vaccine in children]

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle

Association Between Mannose-Binding Lectin and the Sensitivities of Common Infections in Children

Association Between Polymorphisms of the Cytokine and Cytokine Receptor Genes and Immune Response to Hepatitis B Vaccination in a Chinese Han Population.

Association of the -183 polymorphism in the IFN-γ gene promoter with hepatitis B virus infection in the Chinese population

Association of Cytokine Gene Polymorphisms with Long-Term Humoral Response in Children Vaccinated Against Hepatitis B in Infancy

Exploring the Molecular Causes of Hepatitis B Virus Vaccination Response: an Approach with Epigenomic and Transcriptomic Data

Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)/HBeAg(-) mothers: a nested case-control study

Association of Interferon-Gamma Gene Haplotype in the Chinese Population with Hepatitis B Virus Infection.

Differential Analysis of DNA Methylation Profile Between Responder and Nonresponder of Interferon Treatment in Chronic Hepatitis B Patients

CD3Z Genetic Polymorphism in Immune Response to Hepatitis B Vaccination in Two Independent Chinese Populations.

Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine.

Association of Polymorphisms of Cytokine and Tlr-2 Genes with Long-Term Immunity to Hepatitis B in Children Vaccinated Early in Life

Influences Of Mxa Gene-88 G/T And Ifn-Gamma+874 A/T On The Natural History Of Hepatitis B Virus Infection In An Endemic Area

A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.

Association of Interferon-Gamma+874 Gene Single Nucleotide Polymorphism with Susceptibility to Intrauterine HBV Infection

-173G/C polymorphism in the promoter of MIF is associated with hepatitis B virus infection in a Chinese Han population

Relationship Between Cytokine Gene Polymorphism and Susceptibility to Hepatitis B Virus Intrauterine Infection

Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(-) mothers